ABEONA THERAPEUTICS INC.·4

Feb 4, 4:30 PM ET

Silverstein Christine Berni 4

4 · ABEONA THERAPEUTICS INC. · Filed Feb 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Abeona (ABEO) Director Christine Silverstein Sells 20,070 Shares

What Happened Christine Berni Silverstein, a director of Abeona Therapeutics, sold 20,070 shares on 2026-02-02 in an open-market/private sale. The filing reports a weighted-average price of $5.09 for the sale, with proceeds of approximately $102,168. This was a sale (not a purchase) and was reported as done to satisfy tax obligations tied to the vesting of restricted stock awards.

Key Details

  • Transaction date: 2026-02-02; Form 4 filed: 2026-02-04 (timely filing).
  • Shares sold: 20,070; reported weighted-average price: $5.09; total proceeds ≈ $102,168.
  • Price range: shares sold in multiple trades at prices between $5.09 and $5.12 (footnote F2).
  • Reason given (footnote F1): sale to cover tax obligations associated with vesting of restricted stock awards (tax withholding).
  • Shares owned after transaction: not specified in this Form 4.
  • Transaction code: S = Sale.

Context Sales made specifically to cover tax withholding on vested awards are common and typically reflect tax-related liquidity needs rather than a directional view on the company. The filing offers a weighted-average price and states the seller can provide a per-trade price breakdown on request.

Insider Transaction Report

Form 4
Period: 2026-02-02
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-02-02$5.09/sh20,070$102,168137,722 total
Footnotes (2)
  • [F1]The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Signature
/s/ Christine Silverstein|2026-02-02

Documents

1 file
  • 4
    ownership.xmlPrimary

    4